LT
Lotus Pharmaceuticals, Inc.
LTUS · OTC
$0.00 +0.00% (+$0.00)
1M -23.08%
Market Cap $85.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 330.99%
ROA 331.14%
Asset turnover 0.00x
Debt
70 /100
Low Current ratio 0.05x
Net debt/EBITDA -6.10x
Debt/Equity N/A
Stability
33 /100
Unstable Beta -1.60x
Profitable years 0
Rev. volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LTUS
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Zhong Yi Liu
Employees
233
Headquarters
Irvine